Medistim — Earnings Release 2016

Oct 23, 2014

Results for third quarter for Medistim ASA

Results for third quarter for Medistim ASA

Sales for the quarter ended at MNOK 52.0 (MNOK 44.3),

a growth of 17 %. Sales as of September ended at MNOK

148.7 (MNOK 138.8), a growth of 7.1 %. There was a

continued strong growth in the US with 16.2 %

increase in sales for the quarter.

The consumable sales of probes outside the US

increased with 29.3 % for the quarter and 16.4 % year

to date.

Operating profit (EBIT) for the quarter ended at MNOK

10.0 (MNOK 6.5), a growth of 54.1 %. Year to date

operating profit ended at MNOK 28.9 (MNOK 26.6), a

growth of 8.6 %.

The new product MiraQTM Cardiac with new

functionality that increases the value for the

cardiac surgeons was launched at Annual European

Association for Cardiac-Thoracic Surgery (EACTS).